Your session is about to expire
← Back to Search
Tonometry
TonoVera Device Accuracy for Glaucoma
N/A
Recruiting
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline only
Awards & highlights
Study Summary
This trial is testing how accurate the Reichert's Tono-Vera tonometer is compared to other commonly used tonometers.
Who is the study for?
This trial is for men and women aged 18 to 99 in good health who can consent to the study's procedures. It's not for those under 18, unable or unwilling to consent, with significant scleral thinning, allergies to eye measurement anesthetics, or conditions preventing accurate tonometry.Check my eligibility
What is being tested?
The accuracy of the Tono-Vera tonometer for measuring intraocular pressure (IOP) is being tested against other devices like Goldmann Applanation and iCare in patients with glaucoma.See study design
What are the potential side effects?
Potential side effects may include discomfort from eye drops used during IOP measurement and possible irritation from the contact involved in using these devices on the eyes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline only
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline only
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraocular Pressure
Trial Design
1Treatment groups
Experimental Treatment
Group I: IOP MeasurementExperimental Treatment2 Interventions
These are the measurements of the intraocular pressure.
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
248 Previous Clinical Trials
49,241 Total Patients Enrolled
3 Trials studying Glaucoma
156 Patients Enrolled for Glaucoma
Reichert, Inc.Industry Sponsor
2 Previous Clinical Trials
97 Total Patients Enrolled
1 Trials studying Glaucoma
61 Patients Enrolled for Glaucoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My eyes have significant thinning of the white part.You are able to provide signed and dated informed consent formI am under 18 years old.I am between 18 and 99 years old.I am not allergic to proparacaine or fluorescein.I am between 18 and 99 years old and can attend my appointment.
Research Study Groups:
This trial has the following groups:- Group 1: IOP Measurement
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger